Cargando…
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy
BACKGROUND: Diminished systemic serum butyrylcholinesterase (BChE), a biomarker for chronic inflammation, cachexia, and advanced tumor stage, has shown to play a prognostic role in various malignancies. The aim of this study was to investigate the prognostic value of pretherapeutic BChE levels in pa...
Autores principales: | Gensthaler, Lisa, Jomrich, Gerd, Brugger, Jonas, Kollmann, Dagmar, Paireder, Matthias, Bologheanu, Milena, Horn, Alexander, Riegler, Franz M., Asari, Reza, Schoppmann, Sebastian F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244274/ https://www.ncbi.nlm.nih.gov/pubmed/37280384 http://dx.doi.org/10.1007/s00423-023-02938-w |
Ejemplares similares
-
Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE
por: Magar, Pratibha, et al.
Publicado: (2021) -
Platelets as a prognostic factor for patients with adenocarcinoma of the gastroesophageal junction
por: Feka, Joy, et al.
Publicado: (2023) -
Severe Dysphagia is Rare After Magnetic Sphincter Augmentation
por: Bologheanu, Milena, et al.
Publicado: (2022) -
Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development
por: Gu, Yan, et al.
Publicado: (2018) -
Characterization
of the Transient Oxaphosphetane BChE
Inhibitor Formed from Spontaneously Activated Ethephon
por: Lantz, Stephen R., et al.
Publicado: (2013)